Infarm's USD 200 million Series D funding confirms the Middle East as a hotspot for controlled environment agriculture

December 22, 2021
Last Updated:
December 22, 2021
Chemicals More...
Achieving Sustainability More...
Investment More...
Very important

Led by the Qatar Investment Authority (QIA), Infarm's Series D funding follows a USD 100 million round in March 2020. Infarm has now raised over USD 600 million and will be expanding into the U.S., Canadian, Japanese, and European markets, as well into new markets in APAC and the Middle East. With QIA's support, Infarm will build a vertical farming facility in the Middle East that is planned to open in 2023. Regional factors such as energy costs, food demands, and R&D expenditures towards indoor agriculture are attracting participants like Aerofarms, Crop One, GreenFactory Emirates, and N.Thing to the Middle East. With Infarm's inclusion, the Middle East is poised to be a global innovation hotspot for controlled environment agriculture.

For the original news article, click here .

Further Reading

Ampersand secures $3.5 million investment to expand its e-motorcycle and battery swapping network

News Commentary | April 22, 2021

The investment will help Ampersand to scale up its electric motorcycle and battery swapping station network in Rwanda, with aims to add e‑motorcycles in the hundreds to its existing fleet and construct more than a dozen battery swapping stations. Ampersand is also looking to expand beyond Rwanda, ... Not part of subscription

BDC Capital injects $200 million in Canada's deep tech ecosystem

News Commentary | May 21, 2021

The 12‑year, $200 million fund will target between 15 and 20 early‑stage investments in Canada's deep tech startups, with an emphasis on quantum computing, semiconductors, robotics, artificial intelligence, and cybersecurity. Seldom does Canada come up as a leading player in the aforementioned ... Not part of subscription

South Korea to invest almost $1 billion to build national digital library of healthcare data by 2028

News Commentary | September 20, 2021

South Korea joins a growing club of countries focusing on national‑level precision medicine projects to combat rising healthcare costs. Like Singapore, it has managed to get buy‑in from a multiministerial taskforce to greenlight this project. It will invest almost $1 billion from 2023 to 2028 to ... Not part of subscription